Dec 14, 2020 / 09:00PM GMT
Unidentified Participant
Hello, everyone. Hi, we are live, this is Tanya. I am hosting this seminar with Kazia Therapeutics. I have Dr. James Garner with me today. Kazia Therapeutics is an innovative -- excuse me, is an Australian biotech company focused on brain cancer. James, go ahead and take the stage.
James Garner - Kazia Therapeutics Limited - MD, CEO
Tanya, thank you. Ladies and gentlemen, good afternoon. It's a great pleasure to be here. This is our first time presenting at the LD Micro Main Event. And it really caps off very nicely what has been an extraordinary year for Kazia.
And I want to spend the next few minutes just introducing our company and then be really pleased to take some Q&A. But I think all of the key points that I really want to make about the company are, as shown here on this slide.
And I think the first thing to say is we have a really first-class asset that we're developing here in Kazia. It's a drug called paxalisib. It was originally developed by Genentech. Of course, the company well known to folks on this call.
Kazia Therapeutics Ltd at LD Micro Main Event Transcript
Dec 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers